Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
N/A
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 585 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Eikon Therapeutics, Inc. Common Stock
Market Cap
$411.99M
Net Profit Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$412.27M
Net Profit Margin
-13.96%
TTM Avg
-29.79%
3Y Avg
-27.76%
5Y Avg
-25.86%
Market Cap
$408.32M
Net Profit Margin
-57.42%
TTM Avg
-73.98%
3Y Avg
-95.04%
5Y Avg
-95.04%
Market Cap
$407.09M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$406.54M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.00%
Market Cap
$402.01M
Net Profit Margin
0.00%
TTM Avg
-4061.84%
3Y Avg
-2030.92%
5Y Avg
-1353.95%
Market Cap
$425.86M
Net Profit Margin
-157.32%
TTM Avg
-564.37%
3Y Avg
-610.78%
5Y Avg
-554.09%
Market Cap
$432.69M
Net Profit Margin
0.00%
TTM Avg
-90.86%
3Y Avg
-351.90%
5Y Avg
-2330.90%
Market Cap
$437.27M
Net Profit Margin
-0.06%
TTM Avg
-74.67%
3Y Avg
-251.03%
5Y Avg
-526.51%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $411.99M | 0.00% | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $412.27M | -13.96% | -29.79% | -27.76% | -25.86% |
| Carlsmed, Inc. (CARL)vs › | $408.32M | -57.42% | -73.98% | -95.04% | -95.04% |
| Shoulder Innovations, Inc. (SI)vs › | $407.09M | -58.33% | -67.34% | -66.78% | -66.78% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $406.54M | 0.00% | 0.00% | 0.00% | 2.00% |
| Neurogene Inc. (NGNE)vs › | $402.01M | 0.00% | -4061.84% | -2030.92% | -1353.95% |
| Editas Medicine, Inc. (EDIT)vs › | $425.86M | -157.32% | -564.37% | -610.78% | -554.09% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $432.69M | 0.00% | -90.86% | -351.90% | -2330.90% |
| Assembly Biosciences, Inc. (ASMB)vs › | $437.27M | -0.06% | -74.67% | -251.03% | -526.51% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $384.04M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
